biochemicalAgentAntidote |
appearance as argument number 1 |
(documentation biochemicalAgentAntidote EnglishLanguage "(biochemicalAgentAntidote ?AGENT ?SUBSTANCE ?PROCESS) means that the BiologicallyActiveSubstance ?SUBSTANCE has been shown to be effective in treating someone who has been exposed to the BiochemicalAgent ?AGENT when the ?SUBSTANCE is administered via the Process ?PROCESS.") | WMD.kif 916-919 | |
(domain biochemicalAgentAntidote 1 BiochemicalAgent) | WMD.kif 913-913 | biochemicalAgentAntidote の数値 1 引数は BiochemicalAgent の instance では %n |
(domainSubclass biochemicalAgentAntidote 2 BiologicallyActiveSubstance) | WMD.kif 914-914 | biochemicalAgentAntidote の数値 2 引数は 生物活性物質 のsubclass では %n |
(domainSubclass biochemicalAgentAntidote 3 Process) | WMD.kif 915-915 | biochemicalAgentAntidote の数値 3 引数は 工程 のsubclass では %n |
(instance biochemicalAgentAntidote TernaryPredicate) | WMD.kif 912-912 | biochemicalAgentAntidote は 3進述語 の instance では %n |
appearance as argument number 2 |
(format ChineseLanguage biochemicalAgentAntidote "%1 %n{不是} biochemical 病毒解毒制剂 %2 对于 %3") | domainEnglishFormat.kif 288-288 | |
(format ChineseTraditionalLanguage biochemicalAgentAntidote "%1 %n{不是} biochemical 病毒解毒製劑 %2 對於 %3 ") | domainEnglishFormat.kif 287-287 | |
(format EnglishLanguage biochemicalAgentAntidote "%1 %n{doesn't} biochemical agent antidote %2 for %3 ") | domainEnglishFormat.kif 286-286 | |
(termFormat ChineseLanguage biochemicalAgentAntidote "生化剂解毒剂") | domainEnglishFormat.kif 11033-11033 | |
(termFormat ChineseTraditionalLanguage biochemicalAgentAntidote "生化劑解毒劑") | domainEnglishFormat.kif 11032-11032 | |
(termFormat EnglishLanguage biochemicalAgentAntidote "biochemical agent antidote") | domainEnglishFormat.kif 11031-11031 |
statement |
(decreasesLikelihood (and (biochemicalAgentSyndrome ?AGENT ?SYMPTOM) (biochemicalAgentAntidote ?AGENT ?SUBSTANCE ?PROCESS) (instance ?SAMPLE ?SUBSTANCE) (instance ?THERAPY ?PROCESS) (experiencer ?THERAPY ?ORGANISM) (patient ?THERAPY ?SAMPLE)) (attribute ?ORGANISM ?SYMPTOM)) |
WMD.kif 921-929 | biochemicalAgentSyndrome ?AGENT and ?SYMPTOM biochemicalAgentAntidote ?AGENT, ?SUBSTANCE and ?PROCESS ?SAMPLE は ?SUBSTANCE の instance では %n ?THERAPY は ?PROCESS の instance では %n ?ORGANISM が ?THERAPY を experiences %n{ない} ?SAMPLE は ?THERAPY の patient では %n は ?SYMPTOM は ?ORGANISM の attribute では %n を decreases 可能性がある |
appearance as argument number 0 |
(biochemicalAgentAntidote Lewisite Dimercaprol Covering) | WMD.kif 507-507 | biochemicalAgentAntidote Lewisite, Dimercaprol and 覆い |
(biochemicalAgentAntidote NerveAgent Atropine Injecting) | WMD.kif 561-561 | biochemicalAgentAntidote NerveAgent, Atropine and Injecting |
(biochemicalAgentAntidote Soman PyridostigmineBromide Putting) | WMD.kif 581-581 | biochemicalAgentAntidote Soman, PyridostigmineBromide and 置く |